4//SEC Filing
Azad Babak 4
Accession 0000950170-23-027563
CIK 0001809519other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 9:36 PM ET
Size
8.2 KB
Accession
0000950170-23-027563
Insider Transaction Report
Form 4
Azad Babak
See Remarks
Transactions
- Exercise/Conversion
Class A Common Stock
2023-06-08+20,401→ 51,060 total - Exercise/Conversion
Restricted Stock Units
2023-06-08−20,401→ 265,220 total→ Class A Common Stock (20,401 underlying) - Tax Payment
Class A Common Stock
2023-06-08$5.41/sh−7,055$38,168→ 44,005 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximtely equal quarterly installments thereafter for 15 quarters.
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001822193
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 9:36 PM ET
- Size
- 8.2 KB